Weihong Xu
- Immunology top 10%
-
- Epigenetics and DNA Methylation 2
- Renal and related cancers 2
- RNA modifications and cancer 2
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
-
- Acute Myeloid Leukemia Research 3
-
- Genomic variations and chromosomal abnormalities 2
-
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- Bruce A. RoeDietmar J. KappesXi HeVibhuti P. DavéXiao HeÉmmanuelle NicolasHua XiangYi Zhang
- Journals
- Frontiers in Oncology (2 papers)International Journal of Medical Sciences (1 paper)Molecular Cytogenetics (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Weihong Xu
17 papers receiving 573 citations
Peers
Comparison fields: 5 of 64
- Immunology 272
- Molecular Biology 266
- Cancer Research 56
- Oncology 96
- Cell Biology 46
Countries citing papers authored by Weihong Xu
This map shows the geographic impact of Weihong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Xu more than expected).
Fields of papers citing papers by Weihong Xu
This network shows the impact of papers produced by Weihong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Xu. The network helps show where Weihong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weihong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2020 | 3 | |
| 3 | Association of microRNA-933 variant with the susceptibility to gastric cancer. | 2019 | 3 |
| 4 | 2017 | 8 | |
| 5 | 2016 | 13 | |
| 6 | 2016 | 12 | |
| 7 | 2016 | 1 | |
| 8 | 2014 | 11 | |
| 9 | 2014 | 29 | |
| 10 | 2012 | 85 | |
| 11 | 2012 | 20 | |
| 12 | 2012 | 16 | |
| 13 | 2012 | 20 | |
| 14 | 2008 | 6 | |
| 15 | 2008 | 4 | |
| 16 | 2008 | 27 | |
| 17 | 2005 | 316 |
About Weihong Xu
Weihong Xu is a scholar working on Hematology, Genetics and Molecular Biology, having authored 17 papers that have together received 576 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Epigenetics and DNA Methylation (2 papers), Renal and related cancers (2 papers), Genomic variations and chromosomal abnormalities (2 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Immunology (272 citations), Molecular Biology (266 citations) and Cancer Research (56 citations). Weihong Xu has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Bruce A. Roe, Dietmar J. Kappes, Xi He, Vibhuti P. Davé, Xiao He, Émmanuelle Nicolas, Hua Xiang, Yi Zhang, Shibo Li and Xiaoxia Hu. Their work appears in journals such as Frontiers in Oncology, International Journal of Medical Sciences, Molecular Cytogenetics, European Journal of Cancer and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.